 | • レポートコード：GIR-105X02873 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、乳がん治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。乳がん治療薬の種類別市場規模（HER2阻害剤、有糸分裂阻害剤、代謝拮抗剤、アロマターゼ阻害剤）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・乳がん治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Roche Group、Novartis、Pfizer、Bristol-Myers Squibb、Puma Biotech、Verzenio (Eli Lilly)、HALAVEN (Eisai Inc)、AstraZeneca、GlaxoSmithKline、Merck Sharp & Dohme Corp.、Dr Reddy's Laboratories、Celltrion Inc、Biocon、Mylan ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：HER2阻害剤、有糸分裂阻害剤、代謝拮抗剤、アロマターゼ阻害剤 ・用途別分析2016年-2026年：病院、診療所、その他 ・乳がん治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・乳がん治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・乳がん治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・乳がん治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・乳がん治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Breast Cancer Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Breast Cancer Drugs size is estimated to be xx million in 2020 from USD 14980 million in 2019, with a change of XX% between 2019 and 2020. The global Breast Cancer Drugs market size is expected to grow at a CAGR of 6.9% for the next five years.
Market segmentation
Breast Cancer Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
HER2 Inhibitors
Mitotic Inhibitors
Anti-Metabolites
Aromatase Inhibitors
Market segment by Application can be divided into
Hospitals
Clinics
Others
The key market players for global Breast Cancer Drugs market are listed below:
Roche Group
Novartis
Pfizer
Bristol-Myers Squibb
Puma Biotech
Verzenio (Eli Lilly)
HALAVEN (Eisai Inc)
AstraZeneca
GlaxoSmithKline
Merck Sharp & Dohme Corp.
Dr Reddy’s Laboratories
Celltrion Inc
Biocon
Mylan
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Breast Cancer Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Breast Cancer Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 HER2 Inhibitors
1.2.3 Mitotic Inhibitors
1.2.4 Anti-Metabolites
1.2.5 Aromatase Inhibitors
1.3 Market Analysis by Application
1.3.1 Overview: Global Breast Cancer Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Breast Cancer Drugs Market Size & Forecast
1.4.1 Global Breast Cancer Drugs Sales in Value (2016-2026))
1.4.2 Global Breast Cancer Drugs Sales in Volume (2016-2026)
1.4.3 Global Breast Cancer Drugs Price by Type (2016-2026) & (USD/Unit)
1.5 Global Breast Cancer Drugs Production Capacity Analysis
1.5.1 Global Breast Cancer Drugs Total Production Capacity (2016-2026)
1.5.2 Global Breast Cancer Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Breast Cancer Drugs Market Drivers
1.6.2 Breast Cancer Drugs Market Restraints
1.6.3 Breast Cancer Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Roche Group
2.1.1 Roche Group Details
2.1.2 Roche Group Major Business
2.1.3 Roche Group Breast Cancer Drugs Product and Services
2.1.4 Roche Group Breast Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Breast Cancer Drugs Product and Services
2.2.4 Novartis Breast Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Breast Cancer Drugs Product and Services
2.3.4 Pfizer Breast Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Bristol-Myers Squibb
2.4.1 Bristol-Myers Squibb Details
2.4.2 Bristol-Myers Squibb Major Business
2.4.3 Bristol-Myers Squibb Breast Cancer Drugs Product and Services
2.4.4 Bristol-Myers Squibb Breast Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Puma Biotech
2.5.1 Puma Biotech Details
2.5.2 Puma Biotech Major Business
2.5.3 Puma Biotech Breast Cancer Drugs Product and Services
2.5.4 Puma Biotech Breast Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Verzenio (Eli Lilly)
2.6.1 Verzenio (Eli Lilly) Details
2.6.2 Verzenio (Eli Lilly) Major Business
2.6.3 Verzenio (Eli Lilly) Breast Cancer Drugs Product and Services
2.6.4 Verzenio (Eli Lilly) Breast Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 HALAVEN (Eisai Inc)
2.7.1 HALAVEN (Eisai Inc) Details
2.7.2 HALAVEN (Eisai Inc) Major Business
2.7.3 HALAVEN (Eisai Inc) Breast Cancer Drugs Product and Services
2.7.4 HALAVEN (Eisai Inc) Breast Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business
2.8.3 AstraZeneca Breast Cancer Drugs Product and Services
2.8.4 AstraZeneca Breast Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 GlaxoSmithKline
2.9.1 GlaxoSmithKline Details
2.9.2 GlaxoSmithKline Major Business
2.9.3 GlaxoSmithKline Breast Cancer Drugs Product and Services
2.9.4 GlaxoSmithKline Breast Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Merck Sharp & Dohme Corp.
2.10.1 Merck Sharp & Dohme Corp. Details
2.10.2 Merck Sharp & Dohme Corp. Major Business
2.10.3 Merck Sharp & Dohme Corp. Breast Cancer Drugs Product and Services
2.10.4 Merck Sharp & Dohme Corp. Breast Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Dr Reddy’s Laboratories
2.11.1 Dr Reddy’s Laboratories Details
2.11.2 Dr Reddy’s Laboratories Major Business
2.11.3 Dr Reddy’s Laboratories Breast Cancer Drugs Product and Services
2.11.4 Dr Reddy’s Laboratories Breast Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Celltrion Inc
2.12.1 Celltrion Inc Details
2.12.2 Celltrion Inc Major Business
2.12.3 Celltrion Inc Breast Cancer Drugs Product and Services
2.12.4 Celltrion Inc Breast Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Biocon
2.13.1 Biocon Details
2.13.2 Biocon Major Business
2.13.3 Biocon Breast Cancer Drugs Product and Services
2.13.4 Biocon Breast Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 Mylan
2.14.1 Mylan Details
2.14.2 Mylan Major Business
2.14.3 Mylan Breast Cancer Drugs Product and Services
2.14.4 Mylan Breast Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Breast Cancer Drugs Sales by Manufacturer
3.1 Global Breast Cancer Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Breast Cancer Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Breast Cancer Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Breast Cancer Drugs Manufacturer Market Share
3.4.2 Top 6 Breast Cancer Drugs Manufacturer Market Share
3.5 Global Breast Cancer Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Breast Cancer Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Breast Cancer Drugs Market Size by Region
4.1.1 Global Breast Cancer Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Breast Cancer Drugs Revenue by Region (2016-2026)
4.2 North America Breast Cancer Drugs Revenue (2016-2026)
4.3 Europe Breast Cancer Drugs Revenue (2016-2026)
4.4 Asia-Pacific Breast Cancer Drugs Revenue (2016-2026)
4.5 South America Breast Cancer Drugs Revenue (2016-2026)
4.6 Middle East and Africa Breast Cancer Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Breast Cancer Drugs Sales in Volume by Type (2016-2026)
5.2 Global Breast Cancer Drugs Revenue by Type (2016-2026)
5.3 Global Breast Cancer Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Breast Cancer Drugs Sales in Volume by Application (2016-2026)
6.2 Global Breast Cancer Drugs Revenue by Application (2016-2026)
6.3 Global Breast Cancer Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Breast Cancer Drugs Sales by Type (2016-2026)
7.2 North America Breast Cancer Drugs Sales by Application (2016-2026)
7.3 North America Breast Cancer Drugs Market Size by Country
7.3.1 North America Breast Cancer Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Breast Cancer Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Breast Cancer Drugs Sales by Type (2016-2026)
8.2 Europe Breast Cancer Drugs Sales by Application (2016-2026)
8.3 Europe Breast Cancer Drugs Market Size by Country
8.3.1 Europe Breast Cancer Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Breast Cancer Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Breast Cancer Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Breast Cancer Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Breast Cancer Drugs Market Size by Region
9.3.1 Asia-Pacific Breast Cancer Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Breast Cancer Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Breast Cancer Drugs Sales by Type (2016-2026)
10.2 South America Breast Cancer Drugs Sales by Application (2016-2026)
10.3 South America Breast Cancer Drugs Market Size by Country
10.3.1 South America Breast Cancer Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Breast Cancer Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Breast Cancer Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Breast Cancer Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Breast Cancer Drugs Market Size by Country
11.3.1 Middle East & Africa Breast Cancer Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Breast Cancer Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Breast Cancer Drugs Typical Distributors
12.3 Breast Cancer Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Breast Cancer Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Breast Cancer Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Roche Group Basic Information, Manufacturing Base and Competitors
Table 4. Roche Group Major Business
Table 5. Roche Group Breast Cancer Drugs Product and Services
Table 6. Roche Group Breast Cancer Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Novartis Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Major Business
Table 9. Novartis Breast Cancer Drugs Product and Services
Table 10. Novartis Breast Cancer Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Pfizer Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Major Business
Table 13. Pfizer Breast Cancer Drugs Product and Services
Table 14. Pfizer Breast Cancer Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 16. Bristol-Myers Squibb Major Business
Table 17. Bristol-Myers Squibb Breast Cancer Drugs Product and Services
Table 18. Bristol-Myers Squibb Breast Cancer Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Puma Biotech Basic Information, Manufacturing Base and Competitors
Table 20. Puma Biotech Major Business
Table 21. Puma Biotech Breast Cancer Drugs Product and Services
Table 22. Puma Biotech Breast Cancer Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Verzenio (Eli Lilly) Basic Information, Manufacturing Base and Competitors
Table 24. Verzenio (Eli Lilly) Major Business
Table 25. Verzenio (Eli Lilly) Breast Cancer Drugs Product and Services
Table 26. Verzenio (Eli Lilly) Breast Cancer Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. HALAVEN (Eisai Inc) Basic Information, Manufacturing Base and Competitors
Table 28. HALAVEN (Eisai Inc) Major Business
Table 29. HALAVEN (Eisai Inc) Breast Cancer Drugs Product and Services
Table 30. HALAVEN (Eisai Inc) Breast Cancer Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 32. AstraZeneca Major Business
Table 33. AstraZeneca Breast Cancer Drugs Product and Services
Table 34. AstraZeneca Breast Cancer Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 36. GlaxoSmithKline Major Business
Table 37. GlaxoSmithKline Breast Cancer Drugs Product and Services
Table 38. GlaxoSmithKline Breast Cancer Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Merck Sharp & Dohme Corp. Basic Information, Manufacturing Base and Competitors
Table 40. Merck Sharp & Dohme Corp. Major Business
Table 41. Merck Sharp & Dohme Corp. Breast Cancer Drugs Product and Services
Table 42. Merck Sharp & Dohme Corp. Breast Cancer Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Dr Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 44. Dr Reddy's Laboratories Major Business
Table 45. Dr Reddy's Laboratories Breast Cancer Drugs Product and Services
Table 46. Dr Reddy's Laboratories Breast Cancer Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Celltrion Inc Basic Information, Manufacturing Base and Competitors
Table 48. Celltrion Inc Major Business
Table 49. Celltrion Inc Breast Cancer Drugs Product and Services
Table 50. Celltrion Inc Breast Cancer Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Biocon Basic Information, Manufacturing Base and Competitors
Table 52. Biocon Major Business
Table 53. Biocon Breast Cancer Drugs Product and Services
Table 54. Biocon Breast Cancer Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Mylan Basic Information, Manufacturing Base and Competitors
Table 56. Mylan Major Business
Table 57. Mylan Breast Cancer Drugs Product and Services
Table 58. Mylan Breast Cancer Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Global Breast Cancer Drugs Sales by Manufacturer (2019-2021e) & (K Units)
Table 60. Global Breast Cancer Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 61. Market Position of Manufacturers in Breast Cancer Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 62. Global Breast Cancer Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 63. Head Office and Breast Cancer Drugs Production Site of Key Manufacturer
Table 64. Global Breast Cancer Drugs Sales by Region (2016-2021e) & (K Units)
Table 65. Global Breast Cancer Drugs Sales by Region (2021-2026) & (K Units)
Table 66. Global Breast Cancer Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 67. Global Breast Cancer Drugs Revenue by Region (2021-2026) & (USD Million)
Table 68. Global Breast Cancer Drugs Sales by Type (2016-2021e) & (K Units)
Table 69. Global Breast Cancer Drugs Sales by Type (2021-2026) & (K Units)
Table 70. Global Breast Cancer Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 71. Global Breast Cancer Drugs Revenue by Type (2021-2026) & (USD Million)
Table 72. Global Breast Cancer Drugs Price by Type (2016-2021e) & (USD/Unit)
Table 73. Global Breast Cancer Drugs Price by Type (2021-2026) & (USD/Unit)
Table 74. Global Breast Cancer Drugs Sales by Application (2016-2021e) & (K Units)
Table 75. Global Breast Cancer Drugs Sales by Application (2021-2026) & (K Units)
Table 76. Global Breast Cancer Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 77. Global Breast Cancer Drugs Revenue by Application (2021-2026) & (USD Million)
Table 78. Global Breast Cancer Drugs Price by Application (2016-2021e) & (USD/Unit)
Table 79. Global Breast Cancer Drugs Price by Application (2021-2026) & (USD/Unit)
Table 80. North America Breast Cancer Drugs Sales by Country (2016-2021e) & (K Units)
Table 81. North America Breast Cancer Drugs Sales by Country (2021-2026) & (K Units)
Table 82. North America Breast Cancer Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 83. North America Breast Cancer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 84. North America Breast Cancer Drugs Sales by Type (2016-2021e) & (K Units)
Table 85. North America Breast Cancer Drugs Sales by Type (2021-2026) & (K Units)
Table 86. North America Breast Cancer Drugs Sales by Application (2016-2021e) & (K Units)
Table 87. North America Breast Cancer Drugs Sales by Application (2021-2026) & (K Units)
Table 88. Europe Breast Cancer Drugs Sales by Country (2016-2021e) & (K Units)
Table 89. Europe Breast Cancer Drugs Sales by Country (2021-2026) & (K Units)
Table 90. Europe Breast Cancer Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 91. Europe Breast Cancer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 92. Europe Breast Cancer Drugs Sales by Type (2016-2021e) & (K Units)
Table 93. Europe Breast Cancer Drugs Sales by Type (2021-2026) & (K Units)
Table 94. Europe Breast Cancer Drugs Sales by Application (2016-2021e) & (K Units)
Table 95. Europe Breast Cancer Drugs Sales by Application (2021-2026) & (K Units)
Table 96. Asia-Pacific Breast Cancer Drugs Sales by Region (2016-2021e) & (K Units)
Table 97. Asia-Pacific Breast Cancer Drugs Sales by Region (2021-2026) & (K Units)
Table 98. Asia-Pacific Breast Cancer Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 99. Asia-Pacific Breast Cancer Drugs Revenue by Region (2021-2026) & (USD Million)
Table 100. Asia-Pacific Breast Cancer Drugs Sales by Type (2016-2021e) & (K Units)
Table 101. Asia-Pacific Breast Cancer Drugs Sales by Type (2021-2026) & (K Units)
Table 102. Asia-Pacific Breast Cancer Drugs Sales by Application (2016-2021e) & (K Units)
Table 103. Asia-Pacific Breast Cancer Drugs Sales by Application (2021-2026) & (K Units)
Table 104. South America Breast Cancer Drugs Sales by Country (2016-2021e) & (K Units)
Table 105. South America Breast Cancer Drugs Sales by Country (2021-2026) & (K Units)
Table 106. South America Breast Cancer Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 107. South America Breast Cancer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 108. South America Breast Cancer Drugs Sales by Type (2016-2021e) & (K Units)
Table 109. South America Breast Cancer Drugs Sales by Type (2021-2026) & (K Units)
Table 110. South America Breast Cancer Drugs Sales by Application (2016-2021e) & (K Units)
Table 111. South America Breast Cancer Drugs Sales by Application (2021-2026) & (K Units)
Table 112. Middle East & Africa Breast Cancer Drugs Sales by Country (2016-2021e) & (K Units)
Table 113. Middle East & Africa Breast Cancer Drugs Sales by Country (2021-2026) & (K Units)
Table 114. Middle East & Africa Breast Cancer Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 115. Middle East & Africa Breast Cancer Drugs Revenue by Country (2021-2026) & (USD Million)
Table 116. Middle East & Africa Breast Cancer Drugs Sales by Type (2016-2021e) & (K Units)
Table 117. Middle East & Africa Breast Cancer Drugs Sales by Type (2021-2026) & (K Units)
Table 118. Middle East & Africa Breast Cancer Drugs Sales by Application (2016-2021e) & (K Units)
Table 119. Middle East & Africa Breast Cancer Drugs Sales by Application (2021-2026) & (K Units)
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Breast Cancer Drugs Typical Distributors
Table 123. Breast Cancer Drugs Typical Customers
List of Figures
Figure 1. Breast Cancer Drugs Picture
Figure 2. Global Breast Cancer Drugs Sales Market Share by Type in 2020
Figure 3. HER2 Inhibitors
Figure 4. Mitotic Inhibitors
Figure 5. Anti-Metabolites
Figure 6. Aromatase Inhibitors
Figure 7. Global Breast Cancer Drugs Sales Market Share by Application in 2020
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Others
Figure 11. Global Breast Cancer Drugs Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 12. Global Breast Cancer Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. United States Breast Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Canada Breast Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Mexico Breast Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Germany Breast Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. France Breast Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. United Kingdom Breast Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Russia Breast Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Italy Breast Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. China Breast Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Japan Breast Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Korea Breast Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. India Breast Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Southeast Asia Breast Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Australia Breast Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Brazil Breast Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Egypt Breast Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Saudi Arabia Breast Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. South Africa Breast Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Turkey Breast Cancer Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Global Breast Cancer Drugs Sales (2016-2026) & (K Units)
Figure 33. Global Breast Cancer Drugs Production Capacity (2016-2026) & (K Units)
Figure 34. Global Breast Cancer Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 35. Breast Cancer Drugs Market Drivers
Figure 36. Breast Cancer Drugs Market Restraints
Figure 37. Breast Cancer Drugs Market Trends
Figure 38. Global Breast Cancer Drugs Sales Market Share by Manufacturer in 2020
Figure 39. Global Breast Cancer Drugs Revenue Market Share by Manufacturer in 2020
Figure 40. Breast Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 41. Top 3 Breast Cancer Drugs Manufacturer (Revenue) Market Share in 2020
Figure 42. Top 6 Breast Cancer Drugs Manufacturer (Revenue) Market Share in 2020
Figure 43. Global Breast Cancer Drugs Sales Market Share by Region (2016-2026)
Figure 44. Global Breast Cancer Drugs Revenue Market Share by Region (2016-2026)
Figure 45. North America Breast Cancer Drugs Revenue (2016-2026) & (USD Million)
Figure 46. Europe Breast Cancer Drugs Revenue (2016-2026) & (USD Million)
Figure 47. Asia-Pacific Breast Cancer Drugs Revenue (2016-2026) & (USD Million)
Figure 48. South America Breast Cancer Drugs Revenue (2016-2026) & (USD Million)
Figure 49. Middle East & Africa Breast Cancer Drugs Revenue (2016-2026) & (USD Million)
Figure 50. Global Breast Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 51. Global Breast Cancer Drugs Revenue Market Share by Type (2016-2026)
Figure 52. Global Breast Cancer Drugs Price by Type (2016-2026) & (USD/Unit)
Figure 53. Global Breast Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 54. Global Breast Cancer Drugs Revenue Market Share by Application (2016-2026)
Figure 55. Global Breast Cancer Drugs Price by Application (2016-2026) & (USD/Unit)
Figure 56. North America Breast Cancer Drugs Sales Market Share by Country (2016-2026)
Figure 57. North America Breast Cancer Drugs Revenue Market Share by Country (2016-2026)
Figure 58. North America Breast Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 59. North America Breast Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 60. Europe Breast Cancer Drugs Sales Market Share by Country (2016-2026)
Figure 61. Europe Breast Cancer Drugs Revenue Market Share by Country (2016-2026)
Figure 62. Europe Breast Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 63. Europe Breast Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Breast Cancer Drugs Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Breast Cancer Drugs Revenue Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Breast Cancer Drugs Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Breast Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 68. South America Breast Cancer Drugs Sales Market Share by Country (2016-2026)
Figure 69. South America Breast Cancer Drugs Revenue Market Share by Country (2016-2026)
Figure 70. South America Breast Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 71. South America Breast Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Breast Cancer Drugs Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Breast Cancer Drugs Revenue Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Breast Cancer Drugs Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Breast Cancer Drugs Sales Market Share by Application (2016-2026)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
乳がん治療の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Breast cancer is cancer that forms in the cells of the breasts.Breast cancer is cancer that develops from breast tissue. Signs of breast cancer may include a lump in the breast, a change in breast shape, dimpling of the skin, fluid coming from the nipple, a newly inverted nipple, or a red or scaly p…- 卵巣がん薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Ovarian cancer is regarded as one of the most common types of cancer among women. It accounts for more deaths than any other cancer of the female reproductive system, while it ranks 5th in overall women deaths due to cancer. This type of cancer is rarely diagnosed at an early stage, making treatment…
- 頭頸部がん：頭頸部がん薬物療法の世界市場2018-2025 Head and neck cancer is a group of cancers that starts in the mouth, nose, throat, larynx, sinuses, or salivary glands.Current trends indicate that rising geriatric population worldwide, growing cases of target diseases, and availability of improved healthcare services due to government and private …
- 世界の結腸直腸がん治療薬市場 2021：企業別、地域別、種類・用途別 The Colorectal Cancer Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
- 腎臓がんの薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Kidney cancer, also known as renal cancer, is a type of cancer that starts in the cells in the kidney. The two most common types of kidney cancer are renal cell carcinoma (RCC) and transitional cell carcinoma (TCC) of the renal pelvis. These names reflect the type of cell from which the cancer devel…